Search Results - "Diamond, B I"

Refine Results
  1. 1

    A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder by BAKER, D. G, DIAMOND, B. I, VANDER KOLK, B. A, KATZ, R, GILLETTE, G, HAMNER, M, KATZELNICK, D, KELLER, T, MELLMAN, T. A, PONTIUS, E, ROSENTHAL, M, TUCKER, P

    Published in Psychopharmacologia (01-12-1995)
    “…A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to…”
    Get full text
    Journal Article
  2. 2

    A comparison of venlafaxine, trazodone, and placebo in major depression by Cunningham, L A, Borison, R L, Carman, J S, Chouinard, G, Crowder, J E, Diamond, B I, Fischer, D E, Hearst, E

    Published in Journal of clinical psychopharmacology (01-04-1994)
    “…A double-blind, placebo-controlled trial was undertaken to compare the safety and efficacy of venlafaxine and trazodone in patients with major depression. Two…”
    Get more information
    Journal Article
  3. 3

    Plasma dopamine and norepinephrine correlations with psychomotor retardation, anxiety, and depression in non-psychotic depressed patients: a pilot study by Hamner, Mark B., Diamond, Bruce I.

    Published in Psychiatry research (16-10-1996)
    “…The relationship of plasma catecholamine levels to severity of depression and psychomotor retardation was examined in 12 male inpatients who met criteria for…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neuropharmacology of the extrapyramidal system by BORISON, R. L, DIAMOND, B. I

    Published in The journal of clinical psychiatry (01-09-1987)
    “…The neuropharmacology and neuroanatomy of the extrapyramidal system are complex; however, in its most reductionistic state, this system is often described as a…”
    Get full text
    Journal Article
  6. 6

    Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive-compulsive disorder by Marazziti, D, Rotondo, A, Martini, C, Giannaccini, G, Lucacchini, A, Pancioli-Guadagnucci, M L, Diamond, B I, Borison, R, Cassano, G B

    Published in Neuropsychobiology (1994)
    “…Peripheral benzodiazepine (BDZ) receptors were investigated through the binding of the specific ligand 3H-PK-11195 to platelet membranes, in 17 patients…”
    Get more information
    Journal Article
  7. 7

    Phenomenology and neurobiology of cocaine withdrawal: Are they related? by Pathiraja, Ananda, Marazziti, Donatella, Cassano, Giovanni B., Diamond, Bruce I., Borison, Richard L

    “…1. 1. The presence of mood disturbances and platelet 3H-imipramine binding, a putative peripheral serotonergic marker, were evaluted in a group of 27 cocaine…”
    Get full text
    Journal Article
  8. 8

    Phenytoin potentiation of neuroleptic-induced dyskinesias by Sethi, K D, Hitri, A, Diamond, B I

    Published in Movement disorders (1990)
    “…Clinically phenytoin-induced movement disorders may resemble neuroleptic-induced tardive dyskinesia (TD). Neuroleptic-induced TD is thought to be related to an…”
    Get more information
    Journal Article
  9. 9

    Modulation of dopamine receptor sensitivity by estrogen by Gordon, J H, Borison, R L, Diamond, B I

    Published in Biological psychiatry (1969) (01-06-1980)
    “…Postmenopausal females have the highest incidence of tardive dyskinesia, suggesting that loss of ovarian function may predispose them to this condition…”
    Get more information
    Journal Article
  10. 10

    Risperidone: clinical safety and efficacy in schizophrenia by Borison, R L, Pathiraja, A P, Diamond, B I, Meibach, R C

    Published in Psychopharmacology bulletin (1992)
    “…Risperidone represents a unique pharmacology of potent antagonism of both serotonin and dopamine receptors. In a randomized, parallel-group, double-blind trial…”
    Get more information
    Journal Article
  11. 11

    Regional selectivity of neuroleptic drugs: an argument for site specificity by Borison, R L, Diamond, B I

    Published in Brain research bulletin (01-01-1983)
    “…Differences among neuroleptic drugs in their abilities to produce extrapyramidal side-effects have alternatively been ascribed to their inherent…”
    Get more information
    Journal Article
  12. 12

    Treatment approaches in Gilles de la Tourette syndrome by Borison, R L, Ang, L, Hamilton, W J, Diamond, B I, Davis, J M

    Published in Brain research bulletin (01-08-1983)
    “…The neurological disorder Gilles de la Tourette syndrome is most often treated with the receptor blocker haloperidol, which also produces multiple…”
    Get more information
    Journal Article
  13. 13

    Differential membrane effects of general and local anesthetics by Diamond, B I, Havdala, H S, Sabelli, H C

    Published in Anesthesiology (Philadelphia) (01-12-1975)
    “…The authors studied the effects of varying Na+ and Ca++ concentrations and of replacing H2O with D2O in Ringer's solution upon the actions of general and local…”
    Get full text
    Journal Article
  14. 14

    Enhancement of hypophysectomy-induced dopamine receptor hypersensitivity in male rats by chronic haloperidol administration by Gordon, J H, Diamond, B I

    Published in Journal of neurochemistry (01-02-1984)
    “…It has been reported that hypophysectomy (HYPOX) would antagonize the development of a neuroleptic-induced dopamine receptor hypersensitivity, and suggested…”
    Get more information
    Journal Article
  15. 15

    A new animal model for schizophrenia: interactions with adrenergic mechanisms by Borison, R L, Diamond, B I

    Published in Biological psychiatry (1969) (01-04-1978)
    “…Amphetamine-induced stereotyped behavior in animals is proposed as a model for schizophrenia. Chronic amphetamine administration produces stereotyped behavior…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen by Perry, K O, Diamond, B I, Fields, J Z, Gordon, J H

    Published in Brain research (07-12-1981)
    “…Hypophysectomized (HYPOX) or sham HYPOX (SHAM) and ovariectomized rats were injected with either estradiol benzoate (EB, 10 microgram/kg/day x 3) or sesame oil…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20